cjc/ipamorelin blend cjc-1295 + ipamorelin CJC-1295 and Ipamorelin Peptide Injection Ipamorelin blend is Synthesized and Lyophilized in the USA. CJC-1295 + Ipamorelin

In cerebral ischemia and neuroinflammation models, baicalin has been shown to inhibit MMP-9 activity and protect the integrity of the bloodbrain barrier, thereby limiting leukocyte infiltration and edema

Preliminary Results from a Phase 2 Open-Label, Multicenter, Dose Optimization Clinical Study of the Safety, Tolerability, and Pharmacokinetic (PK) and Pharmacodynamic (PD) Profiles of Cfi-400945 As a Single Agent or in Combination with Azacitidine or Decitabine in Patients with Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (TWT-202)

J Subst Abus Treat

Int J Mol Sci 20(21):5500

H., & Seo, Y

This study confirmed the promising concept of designing and testing the efficiency of the catalytic activity of tunable nanozymes for anticancer therapy with negligible off-target toxicity